MoneyWorks4Me

NGL Fine-Chem informs about revised investor presentation

28 May 2024 Evaluate

Pursuant to Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that it enclosed Revised Investor Presentation for the quarter and year ended March 31, 2024. The earlier Investor Presentation had some errors in financials which are now been rectified.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..